Laurel Wealth Planning’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-600
Closed -$158K 69
2022
Q4
$158K Hold
600
0.1% 64
2022
Q3
$135K Sell
600
-11
-2% -$2.67K 0.1% 66
2022
Q2
$149K Buy
611
+11
+2% +$2.7K 0.1% 69
2022
Q1
$145K Buy
+600
New +$138K 0.1% 77

Other funds holding AMGN

Laurel Wealth Planning's AMGN Position: Q1 2023 in Review

Laurel Wealth Planning sold out of Amgen (AMGN) in Q1 2023, closing a stake of 600 shares — an estimated $158K sold.

Laurel Wealth Planning first reported a position in AMGN in Q1 2022 and held it in 4 quarters. The position peaked at $158K in Q4 2022. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Laurel Wealth Planning reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Laurel Wealth Planning sold 600 Amgen shares in Q1 2023, an estimated $158K.
  • Laurel Wealth Planning first reported a position in Amgen in Q1 2022 and held it in 4 quarters.
  • Laurel Wealth Planning's Amgen position peaked at $158K in Q4 2022.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Laurel Wealth Planning's 13F filing for Q1 2023, filed 18 Apr 2023.